News
- Author:
- Jim Kling
Publish date: September 26, 2024
A large prospective study suggests that nasal decolonization could be a simple intervention to reduce surgical site and blood infections.
News
- Author:
- Jim Kling
Publish date: July 26, 2024
The results were based on data from the FDA’s Adverse Event Reporting System.
News
- Author:
- Jim Kling
Publish date: July 26, 2024
Despite some concern about increased risk for MACE with TNFi use, this study suggests no special risk for patients with psoriasis or PsA associated...
News
- Author:
- Jim Kling
Publish date: July 25, 2024
These cells reside in the skin and other tissues and promote the inflammatory response, likely contributing to psoriasis symptoms.
News
- Author:
- Jim Kling
Publish date: July 23, 2024
The rheumatologist emphasized the potential that MSK symptoms are a sign of psoriatic arthritis and therefore should be managed by a rheumatologist...
News
- Author:
- Jim Kling
Publish date: July 1, 2024
Failed primary but successful secondary measures hints that it might be time for a change in cluster headache clinical trial endpoints.
News
- Author:
- Jim Kling
Publish date: June 24, 2024
A Veterans Administration study of migraine found a greater risk of stroke and TIA and a reduced risk of hemorrhagic stroke in men.
News
- Author:
- Jim Kling
Publish date: June 21, 2024
Patient responses suggest CGRP inhibitors might be a good preventative, and that many experience brain fog.
News
- Author:
- Jim Kling
Publish date: June 18, 2024
The first randomized, controlled trial confirms observational studies and could pave the way for insurance coverage.
News
- Author:
- Jim Kling
Publish date: June 17, 2024
Findings could point the way to screening youth for vulnerability to head trauma.
News
- Author:
- Jim Kling
Publish date: June 14, 2024
Researchers are developing intensive testing methods to better understand cognitive function in different migraine phases.
News
- Author:
- Jim Kling
Publish date: June 13, 2024
A prospective phase 4 clinical trial that recruited solely Black and Hispanic patients could shed light on divergent treatment outcomes.
News
- Author:
- Jim Kling
Publish date: June 12, 2024
Pharmacokinetic and pharmacodynamic data show that adult dose is safe and effective for most children.
News
- Author:
- Jim Kling
Publish date: June 12, 2024
Exercise has a long history in MS, and benefits include improvements in fitness, fatigue, depression, and quality...
News
- Author:
- Jim Kling
Publish date: June 6, 2024
Medical entrepreneurship is a hard road, but AGA is ramping up its support for the GI space.
